All times in CET.
The agenda may be subject to change.
08.00 – 09.30
Welcome and Registration
09.30 – 10.15
Moderator: Christine Mhwundwa, International TV Presenter
Welcome Remarks
Alan Donnelly, Chairman, The G20 & G7 Health and Development Partnership (Summit Host)
Hatice Beton, Executive Director, The G20 & G7 Health and Development Partnership (Summit Co-Host)
Keynote
Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO)
H.E. Dr. Jaleela bint Alsayed Jawad Hasan, Minister of Health, Kingdom of Bahrain
H.E. Dr Jean Kaseya, Director General, Africa CDC
H.E. Dr. Hanan Al Kuwari, Advisor to the Prime Minister for Public Health Affairs; Former Minister of Health, Qatar
H.E. Prof Orazio Schillaci, Minister of Health, Italy (Video Message)
Dr. Pakishe Aaron (PA) Motsoaledi, Minister of Health, South Africa, G20 Presidency (2025)
Dr. Sania Nishtar, CEO, GAVI
10.15 – 10.45
Family Photo
Youth Delegation: Model G20 Presentation
Partnership MoU Signing
Theme 1: Reimagining Partnerships & Building Back Public Trust in Global Health
10.45 – 11.40
Panel 1: The future of the G20 & G7 Presidencies and how to keep health on multilateral agendas in a changing geopolitical era?
The G20 and G7 Presidencies are navigating a shifting global order and geopolitical complexities whereby trade tensions, defence spending, and the race for AI often overshadow multilateral health and development goals. Reduced funding announced and further forecast will directly impact the advancement of policy goals. This panel will reflect on the first G20 decade, and explore strategies to secure the role of health and development in the next upcoming G20 cycle starting in 2026. Panelists will be discussing the future role of multilateralism and the ongoing convergence between the G20 and G7 agendas. Panelists will assess the interplay between the G20 and G7 with other multilateral fora such as APEC and BRICS. With the decreasing cuts to global health and overseas development aid, panelists will evaluate the future landscape for health financing.
Chair: Christine Mhwundwa, International TV Presenter
H.E. Dr. Hanan Al Kuwari, Advisor to the Prime Minister for Public Health Affairs; Former Minister of Health, Qatar
H.E. Dr Jean Kaseya, Director General, Africa CDC
Dr Catharina Boehme, Assistant Director-General, External Relations and Governance, WHO
Dr Hajime Inoue, Former Assistant Minister, Ministry of Health, Japan
Dr Philippe Duneton, Executive Director, Unitaid
11.40 – 11.55
Coffee Break
Theme 2: The Role of Legislators & Regional Parliamentary Associations in a Changing World to Help Move From a Plethora of Declarations to Concrete and Implementable Actions
11.55 – 12.00
Special Remarks – Role of Parliamentarian
12.00 – 12.50
H20 Tour De Table: Launch of the NCDs and Mental Health Global Legislators Report
In this roundtable, participants will discuss the recently launched “NCDs and Mental Health Global Legislators Report”. The urgency of the non-communicable diseases (NCDs) and mental health crisis demands accelerated legislative action beyond traditional health sector approaches. Experience with pandemic action and the AMR Legislative Initiative has emphasized the importance of such initiatives to address the key challenges of tackling the biggest global health issue. The roundtable will delve into the roles of parliaments in driving global health, focusing on legislative actions, international collaboration, and national implementation. This dialogue aims to explore how to move beyond declaration to implementation. This launch lays the groundwork for concrete, implementable actions by empowering legislators and fostering international cooperation to address NCDs and mental health globally.
Chair: Alan Donnelly (Summit Co-Host) & Nick Banatvala, Head of Secretariat, UN NCD Taskforce
Hon Min Gemma Arias Vasquez, Minister of Health, Gibraltar
Dr Rosena Allin-Khan, Member of Parliament and South Africa Trade Envoy, UK
H.E. Dr. Jaleela bint Alsayed Jawad Hasan, Minister of Health, Kingdom of Bahrain
Hon Dr Christopher Kalila, Chairperson, Commonwealth Parliamentary Association, Zambia MP
Prof. Agnes Buzyn, President “Evidences”, Former Health Minister, France
12.50 – 13.50
Lunch Break
13.50 – 14.40
H20 Tour De Table: Ask the Politician – The Role of Parliaments, Parliamentary Associations in elevating global health onto future agendas within G20, G7, BRICS, APEC & beyond
The important role of parliaments and policy-makers in international policy-making and implementation does not sometimes deserve the attention it needs. Declarations signed on multilateral fora have implications back at home and the implementation locally and education of constituents on the meaning of these international decisions is mostly left to parliamentarians. In this session parliamentarians and those working with such, will have the opportunity to explore how parliaments and parliamentary associations can advance global health goals through legislative action more strategically. Panelists will assess how they can promote International collaboration, ensure national implementation of global commitments. The discussion will focus on optimizing strategies to enhance dialogue top-down and bottom-up, raise awareness, and build political support, ultimately working towards a healthier global population.
Chair: Dr. Rosena Allin-Khan, Member of Parliament and South Africa Trade Envoy, UK
Dr. Magda Robalo, Chair of UHC 2030, Former Minister of Public Health, Guinea-Bissau
Prof. Agnes Buzyn, President “Evidences”, Former Minister of Health, France
H.E. Amb. Dr. Abdulsalam Al Madani, Roving Ambassador for the GCC and Chair of the PAM Center for Global Studies (CGS)
Elmar Brok, Former MEP, European Parliament
Elisa Scolaro, External Relations Officer, Parliamentary engagement, Department of Health & Multilateral Partnerships, WHO
Hon. Dr. Christopher Kalila, Chairperson, Commonwealth Parliamentary Association, Zambia MP
14.40 – 15.35
Panel 2: Enabling Policy Actions Following the G7 Health Ministers’ Commitment to Cervical Cancer Elimination
Cervical Cancer currently ranks as the fourth most common cancer amongst women globally. Cervical Cancer has recorded 662,000 new cases globally in 2022 alone and has caused the deaths of 348,000 women globally. However, if the right prevention and regulatory measures are put in place by governments, Cervical Cancer could be one of the cancers that could be eliminated first. The G7 under the Presidency of Italy in 2024 has been vocal in its elimination targets, and other G7 countries, including Canada (current Presidency of 2025), are following suit. This roundtable will take stock of Cervical Cancer elimination and explore policy options to support the G7 Health Ministers’ commitments to eliminate Cervical Cancer. It will examine evidence-based strategies in vaccination, screening, treatment, awareness campaigns, service integration, and research. The roundtable will promote sharing best practices and innovative interventions that align with the WHO’s 90-70-90 strategy for global progress.
Chair: Prof. Maarten Postma, Professor of Pharmacoeconomics, University of Groningen
Patricia Lyn McCullagh, Deputy Permanent Representative, Canada
Dr. Csaba L. Dégi, President, European Cancer Organization
15.35 – 16.25
Panel 3: What’s next after a super year for AMR in 2024? How to sustain momentum and fill in the gaps as we move into the 5th Ministerial in 2026?
Reflecting on key 2024 milestones against the fight for antimicrobial resistance (AMR) including the achievements from the G20 and G7 Presidencies, the United Nations High-Level Meeting on AMR, the Jeddah Commitments coming out of the 4th Ministerial Conference hosted by the Kingdom of Saudi Arabia, alongside the recent 2025 DAVOS compact – AMR has experienced somewhat a super year of awareness raising and political action. However, amongst the plethora of declarations published in 2024, what has been implemented? This panel will discuss the 2024 achievements and explore strategies to maintain progress against AMR. Considering the upcoming 2026 Global Action Plan update and the 5th Global High-Level Ministerial (2026), discussions will focus on sustaining momentum despite decreasing global health funding. The panel will also examine how to maximise opportunities in AI-driven drug discovery and advanced diagnostics. Furthermore, it will address optimising the Troika Dialogue on AMR, established through the Jeddah commitments (2025), to ensure continued investment, political commitment, and international collaboration to effectively combat resistance leading up to the 5th Ministerial Conference in Nigeria in June 2026.
Keynote: Dr. Yukiko Nakatani, Assistant Director-General, Antimicrobial Resistance, WHO
Chair: Dr. Sujith Chandy, Executive Director, ICARS
Dr. Farhad Riahi-Nejad, Strategic Advisor, The Fleming Initiative
Vanessa Carter, AMR Patient Survivor, One Health Advocate; Executive Director, The AMR Narrative
Dr. Yvan JF Hutin, Director, Surveillance, Prevention and Control, AMR Division, WHO
Bruce Altevogt, Vice President, Public Health Policy And Strategic Engagement, Biomerieux
16.25- 17.05
Recommendations & Break-Out Sessions
Development of Recommendations for CTA + Q&A
Guiding Questions for Assigned Groups Following Discussions on Panels and Roundtables on Day 1
17.05 – 18.05
Panel 4: How will the Future Determinants of Health Help Enable and Finance Innovation in Healthcare and Support Evidence-based Policy Making for a Whole-of-Society Approach?
The rapidly changing social, economic, environmental, and technological landscape is immensely shaping the future of our healthcare systems. This panel will assess the future determinants of health and innovation in healthcare services and access. Panelists will discuss the value of personalized care, including through digital tools like AI, addressing social disparities, and ensuring equitable outcomes via data-driven policies and cross-sector collaboration. The focus is on a “whole-of-society” approach, integrating stakeholders and systems to improve health for all.
Keynote: Professor Dr. Kausik Ray, Professor of Public Health, Department of Public Health and Primary Care, Imperial College, London & Honorary Consultant Cardiologist, Imperial College NHS Trust
Chair: Dr. Etienne Krug, Director, Department of Social Determinants of Health, WHO
Dr. Poonam Dhavan, Director of the Migration Health Division, International Organization for Migration (IOM)
H.E. Ambassador Christophe Payot, Permanent Representative, Permanent Mission of Belgium to the United Nations Office and other International Organizations in Geneva
David Reddy, Director General, IFPMA
Eng. Khaled Habib Al Attar, Director-General of DIHAD Sustainable Humanitarian Organisation
Dr. Roland Göhde, Chair of the Board, GHA – German Health Alliance, and Co-Founder & CEO, Virchow Foundation
Dr. Ozge Aydogan, Director and Curator in Chief, Beyond Lab
18.05 – 18.15
Wrap-Up & Closing Remarks Day 1
18.30 – 21.00